Search Results | Showing 41 - 50 of 123 results for "Biotech" |
| | | ... over international equity ETFs, which have become more expensive as the Australian dollar has weakened," Neiron said. New biotech ETF Last week, ETF Securities launched a new ETF that will invest in 120 international healthcare biotech stocks for a fee ... |
| | | | ... at the time of publication, the highest since January 2007. We recently profiled Ohanessian's career from running a biotech company to spearheading Praemium's growth trajectory. Read about it here. |
| | | | ... operating in the 'toy domain', with the industry yet to be disrupted in any meaningful way. Drawing a comparison to the biotech sector, Association of Superannuation Funds of Australia chief executive Martin Fahy said fintech success stories don't stack ... |
| | | | ... chapter for TelstraSuper. We'll be supporting promising opportunities in the fields of healthcare, technology, cleantech and biotech based on scientific research and aiming to turn these into outstanding returns for our members," Miller said. "Unlike ... |
| | | | Lonsec's rating of Arnhem Investment Management's global separately managed account was upgraded in its latest round of reviews. Arnhem's global SMA, the Australia+ SMA, is now 'Recommended' by the ratings house, with Lonsec highlighting its "highly ... |
| | | | ... world market," Curnock Cook said. The BTF will be Australia's largest life sciences fund, with private investors including biotech company CSL Limited, AustralianSuper, HESTA, Statewide and Hostplus. The fund is expected to make its first investments ... |
| | | | ... than the long-term benefits of innovation. However, investment manager QIC says that the recent success of one of its biotech investments, Hatchtech, demonstrates the great potential of the market. Melbourne-based Hatchtech is the developer of a next ... |
| | | | ... with a focus on technology, including: M.H. Carnegie & Co (general and medical technology), Brandon Capital Partners (biotech), and Blackbird Ventures (software). |
| | | | ... said capital stewardship is not about an ESG or values-based overlay because that could be anybody's values. He cited biotech and genetic modification as an example where values-based investing becomes tricky. He said another example at Aberdeen was ... |
| | | | Sunsuper is welcoming two new board members this week and the appointments will form an integral part of a cultural and digital transformation at the $35 billion fund. Joining Sunsuper's board are Theresa Moltoni and Professor Mark Harvey. The pair ... |
|